Biotech Stocks to Watch for October 28, 2015
( click to enlarge )
Just one more push to change this trend. XOMA Corp (NASDAQ:XOMA) was one of the winners on Tuesday, as the stock closed up 24 cents on the day with high volumes. From a technical standpoint, the stock is in a short-term Bull Market with share price above 9, 13, 20 & 50 EMAs. The MACD is rising in the positive territory and the accumulation line is moving higher. There is a Big gap to fill above 1.43, so watch the stock closely tomorrow.
( click to enlarge )
Zafgen Inc (NASDAQ:ZFGN) is one for the bottom pickers. Looking at the technical chart, there are early signs in the indicators, that a larger move may be coming. The MACD indicator is showing signs of reversal and the RSI is deeply oversold, raising the probability of a short-term bounce. If the potential "buy" signal confirms itself, I will be looking for a move to the resistance area at 11.70-12.25 at the very least. The stock could have good upside potential, so watch the stock closely on Wednesday.
( click to enlarge )
Aerie Pharmaceuticals Inc (NASDAQ:AERI) broke through resistance and out of the base formation. Technical indicators are looking Bullish with the RSI rising while the MACD is cutting above its signal line. With the spike in volume and momentum surging in today's trading sesison, there is a high possibility that the stock price can appreciate even more in value during the coming sessions. Keep it on your watch list going forward.
( click to enlarge )
Avalanche Biotechnologies Inc (NASDAQ:AAVL) stock starts showing buy signals again. However, after the recent decline in share price, a good entry point will be only in a break of its 20-day EMA at $8.35 on heavy volume.
( click to enlarge )
Juno Therapeutics Inc (NASDAQ:JUNO) has been under the radar for the last several weeks and appears that the stock still has more fuel in its tank for a move higher. The stock broke a key resistance line today with an up-move of $3.01 to 52.99. Next resistance is now seen at 55.
( click to enlarge )
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) broke out of an important consolidation area with a long white candlestick. This new rally should at least push the stock to $13.2
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
Labels: AAVL, AERI, JUNO, XOMA, ZFGN, ZIOP
